Dolezal O - Search Results

1

Phage surface presentation and secretion of antibody fragments using an adaptable phagemid vector.

Lah M, Goldstraw A, White JF, Dolezal O, Malby R, Hudson PJ. Lah M, et al. Among authors: dolezal o. Hum Antibodies Hybridomas. 1994;5(1-2):48-56. Hum Antibodies Hybridomas. 1994. PMID: 7858183

2

Recombinant single-chain antibody peptide conjugates expressed in Escherichia coli for the rapid diagnosis of HIV.

Lilley GG, Dolezal O, Hillyard CJ, Bernard C, Hudson PJ. Lilley GG, et al. Among authors: dolezal o. J Immunol Methods. 1994 May 16;171(2):211-26. doi: 10.1016/0022-1759(94)90041-8. J Immunol Methods. 1994. PMID: 7515087

3

Agglutination-inhibition assay for the detection of recombinant proteins tagged with peptide epitopes.

Dolezal O, Coia G, Hudson PJ. Dolezal O, et al. Biotechniques. 1997 May;22(5):897-904. doi: 10.2144/97225st02. Biotechniques. 1997. PMID: 9149872 Free article.

4

Escherichia coli expression of a bifunctional Fab-peptide epitope reagent for the rapid diagnosis of HIV-1 and HIV-2.

Dolezal O, Coia G, Guthrie RE, Lilley GG, Hudson PJ. Dolezal O, et al. Immunotechnology. 1995 Dec;1(3-4):197-209. doi: 10.1016/1380-2933(95)00021-6. Immunotechnology. 1995. PMID: 9373348

5

ScFv multimers of the anti-neuraminidase antibody NC10: shortening of the linker in single-chain Fv fragment assembled in V(L) to V(H) orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers.

Dolezal O, Pearce LA, Lawrence LJ, McCoy AJ, Hudson PJ, Kortt AA. Dolezal O, et al. Protein Eng. 2000 Aug;13(8):565-74. doi: 10.1093/protein/13.8.565. Protein Eng. 2000. PMID: 10964986

6

Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting.

Kortt AA, Dolezal O, Power BE, Hudson PJ. Kortt AA, et al. Among authors: dolezal o. Biomol Eng. 2001 Oct 15;18(3):95-108. doi: 10.1016/s1389-0344(01)00090-9. Biomol Eng. 2001. PMID: 11566601 Review.

7

Single-chain Fv multimers of the anti-neuraminidase antibody NC10: the residue at position 15 in the V(L) domain of the scFv-0 (V(L)-V(H)) molecule is primarily responsible for formation of a tetramer-trimer equilibrium.

Dolezal O, De Gori R, Walter M, Doughty L, Hattarki M, Hudson PJ, Kortt AA. Dolezal O, et al. Protein Eng. 2003 Jan;16(1):47-56. doi: 10.1093/proeng/gzg006. Protein Eng. 2003. PMID: 12646692

8

Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.

Robert R, Dolezal O, Waddington L, Hattarki MK, Cappai R, Masters CL, Hudson PJ, Wark KL. Robert R, et al. Among authors: dolezal o. Protein Eng Des Sel. 2009 Mar;22(3):199-208. doi: 10.1093/protein/gzn052. Epub 2008 Oct 16. Protein Eng Des Sel. 2009. PMID: 18927231

9

Design and application of diabodies, triabodies and tetrabodies for cancer targeting.

Todorovska A, Roovers RC, Dolezal O, Kortt AA, Hoogenboom HR, Hudson PJ. Todorovska A, et al. Among authors: dolezal o. J Immunol Methods. 2001 Feb 1;248(1-2):47-66. doi: 10.1016/s0022-1759(00)00342-2. J Immunol Methods. 2001. PMID: 11223068 Review.

10

Shark IgNAR antibody mimotopes target a murine immunoglobulin through extended CDR3 loop structures.

Simmons DP, Streltsov VA, Dolezal O, Hudson PJ, Coley AM, Foley M, Proll DF, Nuttall SD. Simmons DP, et al. Among authors: dolezal o. Proteins. 2008 Apr;71(1):119-30. doi: 10.1002/prot.21663. Proteins. 2008. PMID: 17932913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters